EU HTA & EUnetHTA21 – The pathway for implementation of the EU HTA system in 2025 – helping companies prepare for submission

28. Mar 2022 — Register now

Join EUNetHTA,  EUCOPE and MAP Patient Access as they discuss the implementation of the EU HTA system in 2025. This webinar will help attendees to:

  • Understand details about the stepwise entry into force of the EU HTA starting in January 2025
  • Learn how EUnetHTA21 will develop the methodology and procedural rules until 2025
  • Understand details about the EUnetHTA21 pilots and the benefits for companies to participate
  • Learn about how companies can seek Scientific Advice for their submissions and dossiers
  • Understand how the EU HTA will be integrated into national P&R decision making
  • Understand how the comparators & endpoints will be selected for the multinational clinical assessment
  • Learn how your company can benefit from the joint approach
  • Understand the pricing implications for the EU4 countries and the UK

You can email questions to enquiries@mappatientaccess.com.

Please note, this webinar is only available to BioPharma and MedTech companies.

Back to the events overview